As clinicians increasingly encounter patients with IBD as well as obesity, diabetes, or metabolic liver disease, there is a clear need to synthesize what is known about safety, metabolic effects, and IBD-specific outcomes to support evidence-informed clinical decision-making, explains senior investigator and study author Jolle St-Pierre, MD, PhD, FRCPC, a clinical assistant professor in the Division of Gastroenterology and Hepatology at the University of Calgary, Canada, in an email to Gastro Today
Key benefits include: Simple dose selection Comfortable grip and injection angle Reduced preparation steps Portable pen-style format These features significantly improve patient experience compared with traditional injection methods
Bookmark the new foodaway.org website for easy access to all the great content, tools, and resources from IFMA The Food Away from Home Association
I know some meds you can probably find a little cheaper (knockoff compound meds), but Ill take the solid customer service, no headache support with RO